|
|
Article: Asthma -- Therapeutic Developments and Markets.
- Article from:
- M2 Presswire
- Article date:
- December 18, 2000
CopyrightCOPYRIGHT 2000 Normans Media Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
M2 PRESSWIRE-18 December 2000-SMI: Asthma -- Therapeutic Developments and Markets (C)1994-2000 M2 COMMUNICATIONS LTD
RDATE:18122000
Amy D'Orazio (January 2001)
Asthma is a chronic respiratory disease which currently affects 3 million people in the UK and 14.6 million people in the US. The UK, Australia, New Zealand, and Ireland have the highest prevalence of asthma in the world.
Asthma is the leading cause of childhood hospital admissions and absenteeism from work and is the cause of approximately 5000 deaths per year in the US and 1100 deaths per year in the UK.
Despite extensive progress in the understanding of the etiology and treatment of asthma, ...